Careers Header Bg
Regask Q1
REGASK SPONSORS

7th Annual Life Science Regulatory Intelligence & Strategy Conference

FEBRUARY 26-27, 2025  |  ARLINGTON, VA

Hotel AKA Alexandria, Virginia 22314

Learn more about our session
 
 

Meet our team

Join Caroline Shleifer, Founder & CEO, and Kelli Madden, Senior Regulatory Intelligence Manager, as they lead an insightful session on how AI-driven regulatory intelligence is transforming compliance strategies.

Don’t miss Kelli’s deep dive into RegASK’s cutting-edge technology and its real-world impact on streamlining regulatory workflows.

JD Deleon, Business Development Director, will be at the RegASK booth, connecting with professionals across the industry and showcasing how our AI-driven solutions can help organizations navigate global regulatory challenges.

Q1 Conference Attendees

JD Deleon

Business Development Director

Caroline Shleifer

Founder & CEO

Kelli Madden

Senior Regulatory Intelligence Manager

RegASK presentations

DAY 1: February 26, 2025 | 9:00 AM – 9:45 AM

Session Title: Autonomous Regulatory Intelligence – The Future of Regulatory Intelligence

Speakers:
Caroline Shleifer
, Founder and CEO (RegASK)

Kelli Madden, Senior Regulatory Intelligence Manager (RegASK)

As regulatory landscapes become increasingly complex, staying compliant is more challenging than ever. In this session, Kelli Madden will explore how AI and Machine Learning (ML) can proactively recommend regulatory actions, ensuring compliance while reducing manual effort.

Key Takeaways:
How AI seamlessly integrates into regulatory intelligence•
• Real-time monitoring and automation of regulatory updates
• Transforming compliance into a proactive, data-driven process
• Overcoming challenges in AI adoption for regulatory affairs

Join us as we showcase RegASK’s cutting-edge AI-driven regulatory solutions designed to simplify compliance and enhance decision-making.


DAY 2: February 27, 2025 | 1:30 PM – 2:30 PM

Session Title: Solutions for Regulatory Professionals to Ensure Compliance With Global Regulations

Speakers:
Carla Amstein
, Global Head Regulatory Intelligence (Alcon)

Kelli Madden, Senior Regulatory Intelligence Manager (RegASK)

Key Takeaways:
• Methods for seamless compliance management
• Regulatory reporting solutions for data and reports

Your trusted partner in regulatory intelligence

RegASK is proud to sponsor the 7th Annual Life Science Regulatory Intelligence & Strategy Conference, bringing together industry leaders to discuss the future of regulatory intelligence.

As pioneers in AI-driven regulatory solutions, RegASK helps organizations navigate global regulations with speed and accuracy. Our platform provides:

  • Automated regulatory insights tailored to your industry
  • Real-time tracking of regulatory changes and impact analysis
  • A global network of 1,700+ regulatory experts

Join us in shaping the future of regulatory intelligence at this premier event!



Our solution

RegASK leverages advanced AI and machine learning to help businesses in highly regulated industries streamline their regulatory compliance processes and stay ahead of the curve. Our cutting-edge solution automates regulatory research, provides vital insights, and empowers regulatory affairs teams to become strategic partners in driving business growth.

Resources

RegASK Featured in Gartner’s Market Guide for Regulat…
We’re thrilled to share that RegASK has been included in Gartner’s Market Guide for Regulatory Intelligence Solutions! This recognition …
Read more
Portuguese Industry Opposes U.S. Proposal for Cancer Wa…
The United States Health Authority is considering the introduction of mandatory cancer warning labels on alcoholic beverages, a measure simi…
Read more
The 2025 State of Regulatory Affairs and Compliance Rep…
Is your organization prepared for 2025’s regulatory complexities? The regulatory landscape in 2025 is more complex than ever, with new adv…
Read more
US FDA Announces Draft Guidance on AI Use in Regulatory…
On January 6, 2025, the U.S. Food and Drug Administration (FDA) announced the release of a draft guidance titled “Considerations for the U…
Read more
US FDA Announces Public Meeting on Paediatric Legislati…
The Food and Drug Administration (FDA) has scheduled a public meeting titled “Interested Parties Meeting: Implementation of the Best Pharm…
Read more
FDA (USA) Issues Final Guidance on Predetermined Change…
On December 4, 2024, the U.S. Food and Drug Administration (FDA) issued its final guidance, “Marketing Submission Recommendations for …
Read more
China Approves Carbon Ion Therapy, Marking Cancer Treat…
On September 29, 2024, the National Medical Products Administration (NMPA) approved the registration of the Carbon Ion Therapy System. This …
Read more